We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Epstein-Barr virus-positive CD30+ B-cell lymphoproliferative disease with histologic features resembling grade III lymphomatoid granulomatosis induced by methotrexate.
- Authors
Quaye, Elizabeth H.; D'Angelis, Christopher; Powell, Jennifer
- Abstract
Methotrexate (MTX) is a first-line systemic medication used to treat rheumatoid arthritis because of its immunomodulatory effects. However, MTX has also been linked to the development of lymphoproliferative disorders (LPD) in patients with rheumatoid arthritis. We describe a patient with long-standing rheumatoid arthritis treated with MTX who developed cutaneous Epstein-Barr virus (EBV)- positive B cell lymphoproliferative disease resembling grade III lymphomatoid granulomatosis localized to the right leg. The lymphomatoid process resolved with withdrawal of the MTX. The pathogenesis of iatrogenic lymphoproliferative disorder was most likely triggered by the rheumatoid inflammation and the immunosuppressing effects of MTX, which led to EBV reactivation. We recommend a trial of MTX discontinuation prior to considering chemotherapy in patients with rheumatoid arthritis treated with MTX who develop EBV-positive B cell lymphoproliferative disease resembling a high grade B-cell lymphoma.
- Subjects
B cells; LYMPHOPROLIFERATIVE disorders; METHOTREXATE; PATHOGENESIS; IMMUNOSUPPRESSION
- Publication
Dermatology Online Journal, 2023, Vol 29, Issue 1, p1
- ISSN
1087-2108
- Publication type
Art Reproduction
- DOI
10.5070/D329160212